Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01850511 · ClinicalTrials.gov registry record · NA
The Effect of Nasal Hair on Nasal Obstruction
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01850511: Completed NA study, sponsored by Mayo Clinic.
NCT01850511 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01850511, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Nasal obstruction is a common complaint prompting presentation to an otolaryngologist. Many studies have been performed quantifying and describing the impact of a number of factors on symptoms of nasal obstruction, including anatomical, neoplastic, infectious, and inflammatory causes. Despite this scrutiny, no attention has been paid to the nasal vibrissae as a potential anatomical contributor to nasal obstruction. The proposed study intends to elucidate that contribution, if any exists.
Interventions
- PROCEDURE Vibrissae trimming
- DRUG Application of oxymetazoline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-05 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01850511
The ClinicalTrials.gov registry entry for NCT01850511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vibrissae trimming is the first listed.
NCT01850511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01850511 about?
NCT01850511 is a clinical study titled "The Effect of Nasal Hair on Nasal Obstruction". Nasal obstruction is a common complaint prompting presentation to an otolaryngologist. Many studies have been performed quantifying and describing the impact of a number of factors on symptoms of nasal obstruction, including anatomical, neoplastic, infectious, and inflammatory causes. Despite this s...
What is the current status of trial NCT01850511?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-05. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01850511?
The interventions under investigation include: Vibrissae trimming (PROCEDURE), Application of oxymetazoline (DRUG).
Who is sponsoring clinical trial NCT01850511?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.